<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Uyarıcı madde kullanıcıları &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/uyarici-madde-kullanicilari/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 25 Jan 2026 00:37:33 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Uyarıcı madde kullanıcıları &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Naltrexone Study: Combatting Opioid Overdose in Stimulant Users</title>
		<link>https://bioengineer.org/naltrexone-study-combatting-opioid-overdose-in-stimulant-users/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 25 Jan 2026 00:37:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[HIV risk]]></category>
		<category><![CDATA[HIV riskli bireyler]]></category>
		<category><![CDATA[İşte 5 uygun etiket (virgülle ayrılmış): **İntramüsküler naltrekson]]></category>
		<category><![CDATA[Makalenin içeriğine ve anahtar kelimelerine göre en uygun 5 etiket: **Naltrexone]]></category>
		<category><![CDATA[Opioid aşır doz önleme]]></category>
		<category><![CDATA[Opioid Overdose Prevention]]></category>
		<category><![CDATA[Pilot RCT** **Açıklama:** 1. **İntramüsküler naltrekson:** Çalışmanın temel m]]></category>
		<category><![CDATA[Randomized controlled trial** **Açıklama:** 1. **Naltrexone:** Çalışmanın temelini oluşturan müdahale ajanıdır. Anahtar kelime olarak zaten belirtilmiş ve mak]]></category>
		<category><![CDATA[Stimulant users]]></category>
		<category><![CDATA[Uyarıcı madde kullanıcıları]]></category>
		<guid isPermaLink="false">https://bioengineer.org/naltrexone-study-combatting-opioid-overdose-in-stimulant-users/</guid>

					<description><![CDATA[Recent research efforts have underscored the pressing need for innovative strategies aimed at mitigating the devastating impact of opioid overdoses, particularly among marginalized populations. A notable study titled the NOD (Naltrexone for Overdose Prevention) protocol shines a spotlight on one potential intervention: the use of intramuscular naltrexone. This clinical trial specifically focuses on individuals who [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320518</post-id>	</item>
	</channel>
</rss>
